A human liver microphysiology platform for studying physiology, drug safety, and disease

Posted · Add Comment

Currently available animal and human liver models provide limited predictions of human drug efficacy and toxicity, primarily due to metabolic differences and the limited ability of simple 2-D models to recapitulate the complex cellular interactions that lead to toxicity. To fill this gap we have developed a novel 4 cell type, 3-D, microfluidic, human liver model with the ability to monitor multiple cellular toxicity and human disease related functions over at least 28 days.

This full article appears on <a href="https://www.sciencedaily.com/releases/2016/02/160229182549.htm">Science Daily</a>

Leave a Reply

Your email address will not be published. Required fields are marked *